Serina Therapeutics

SERNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$35.994 M

$2.40 +2.13%

Close of 7 Aug 2026

Revenue

$130.0K

#3603 by revenue

Earnings

-$19.2M

Loss-making

Shares outstanding

12,314,159

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#367Lantern PharmaLTRN$36.5M
#368NanoviricidesNNVC$36.1M
#369Serina TherapeuticsSER$36.0M
#370BeyondSpringBYSI$35.8M
#371EnlivexENLV$35.0M

Where these numbers come from

Share counts and financials for Serina Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.